Research even suggests it can change users' sense of smell, and other common side effects include diarrhoea, nausea, 'sulphur ...

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

After a blood test during her annual physical uncovered low hemoglobin levels, she underwent numerous tests and learned she had Stage 3 colorectal cancer. “They found a softball- and golf ball ...

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.